MetricSide LogoMetricSide
Learn
  1. Home
  2. Companies
  3. Healthcare
  4. RNA
OverviewMetricsPricesRevenue & ProfitAssets & LiabilitiesCash FlowMarginsPrice RatiosOthers
MetricSide

Standardized stock fundamentals and valuation metrics. Analyze revenue, EBITDA, free cash flow, and more with interactive charts.

Stock Sectors

  • Technology
  • Healthcare
  • Financials
  • Consumer
  • Industrials
  • Energy
  • Real Estate
  • Materials

Legal & Contact

  • Terms of Service
  • Privacy Policy
  • Contact Us
Not Financial Advice: MetricSide is a data aggregation and visualization tool. Nothing on this website constitutes investment advice, a recommendation, or a solicitation to buy or sell any security. All data is provided for informational and educational purposes only. Past performance is not indicative of future results. Always consult a qualified financial professional before making investment decisions. Data accuracy is not guaranteed — verify critical information against official sources.

© 2026 MetricSide. All rights reserved.

Atrium Therapeutics (RNA) Cash Flow 2026

Operating cash flow, free cash flow, FCF margin, and earnings quality

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow
$-31.14M
Free Cash Flow
$-33.24M
FCF Margin
N/A
FCF / Net Income
2.0
Operating Cash Flow
Cash generated from core business operations
Free Cash Flow
Cash the business generates after maintaining itself
FCF Margin (%)
10%+ signals a capital-efficient business model
FCF / Net Income
Above 1 means earnings are backed by real cash